Literature DB >> 14527373

Changing constituents of genitourinary cancer in recent 50 years in Beijing.

Fangliu Gu1.   

Abstract

OBJECTIVE: To assess the changes in constituents of genitourinary cancer inpatients in Beijing following the growing economy of China.
METHODS: Urological inpatients treated from January 1951 to December 2000 at the Institute of Urology, Peking University were studied retrospectively.
RESULTS: In the period of about 50 years 28 474 urological inpatients were reviewed. Cancer patients in 1951-1965 and 1966-2000 comprised 19.5% and 28.2%, respectively [corrected]. Since the 1970s the incidence rates of renal cancer and prostate cancer increased dramatically from 10.4% to 28.7% and from 3.3% to 13.4%, respectively.
CONCLUSION: The introduction of new diagnostic instruments, the expansion of the aged population and a high fat diet are considered to be responsible for the change of constituents of genitourinary cancer inpatients.

Entities:  

Mesh:

Year:  2003        PMID: 14527373

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi.

Authors:  Lunbiao Cui; Yuan Shi; Jie Qian; Guidong Dai; Yubang Wang; Yankai Xia; Jianfeng Chen; Ling Song; Shouling Wang; Xinru Wang
Journal:  Urol Res       Date:  2006-07-29

2.  TAT-Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl-2, caspase-3 and survivin expression.

Authors:  Jun Li; Haifeng Wang; Zhen Ma; Wenxing Fan; Yanfeng Li; Bingbing Han; Zhijia Zhang; Jiansong Wang
Journal:  Exp Ther Med       Date:  2012-03-21       Impact factor: 2.447

3.  Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China.

Authors:  Xiao Wang; Shuai Wang; Yi-wei Lin; Jian Wu; Hong Chen; Ye-qing Mao; Xiang-yi Zheng; Cheng Zhou; Li-ping Xie
Journal:  Med Oncol       Date:  2011-08-28       Impact factor: 3.064

4.  Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.

Authors:  Kun Tang; Chenghe Wang; Zhong Chen; Hua Xu; Zhangqun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  The association between overall survival of prostate cancer patients and hypertension, hyperglycemia, and overweight in Southern China: a prospective cohort study.

Authors:  Hua Xu; Li-min Zhang; Jun Liu; Guan-xiong Ding; Qiang Ding; Hao-wen Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

6.  Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China.

Authors:  LiXin Hua; Di Qiao; Bin Xu; NingHan Feng; Gong Cheng; JieXiu Zhang; NingHong Song; Wei Zhang; Jie Yang; JianGang Chen; YuanGeng Sui; HongFei Wu
Journal:  Med Oncol       Date:  2010-01-14       Impact factor: 3.064

7.  Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.

Authors:  Shibao Li; Zhiyuan Wu; Yuming Chen; Zhihua Kang; Hua Wang; Ping He; Xinju Zhang; Tingting Hu; Qunfeng Zhang; Yanqun Cai; Xiao Xu; Ming Guan
Journal:  Tumour Biol       Date:  2015-11-11

8.  Radiotherapy induced hip joint avascular necrosis-Two cases report.

Authors:  Lukasz Michalecki; Dorota Gabryś; Roland Kulik; Jerzy Wydmański; Krystyna Trela
Journal:  Rep Pract Oncol Radiother       Date:  2011-05-31

9.  Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.

Authors:  X Zeng; Z Hu; Z Wang; J Tao; T Lu; C Yang; B Lee; Z Ye
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-01-14       Impact factor: 5.554

10.  Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.

Authors:  Yongheng Bai; Yaping Yu; Bin Yu; Jianrong Ge; Jingzhang Ji; Hong Lu; Jia Wei; Zhiliang Weng; Zhihua Tao; Jianxin Lu
Journal:  BMC Med Genet       Date:  2009-12-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.